Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 843

1.

Pelvic lymph node dissection in prostate cancer.

Briganti A, Blute ML, Eastham JH, Graefen M, Heidenreich A, Karnes JR, Montorsi F, Studer UE.

Eur Urol. 2009 Jun;55(6):1251-65. doi: 10.1016/j.eururo.2009.03.012. Epub 2009 Mar 10. Review.

PMID:
19297079
2.

Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy.

Heidenreich A, Ohlmann CH, Polyakov S.

Eur Urol. 2007 Jul;52(1):29-37. Epub 2007 Apr 11. Review.

PMID:
17448592
3.

Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection.

Briganti A, Abdollah F, Nini A, Suardi N, Gallina A, Capitanio U, Bianchi M, Tutolo M, Passoni NM, Salonia A, Colombo R, Freschi M, Rigatti P, Montorsi F.

Eur Urol. 2012 Jun;61(6):1132-8. doi: 10.1016/j.eururo.2011.11.008. Epub 2011 Nov 12.

PMID:
22099610
4.

Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.

Da Pozzo LF, Cozzarini C, Briganti A, Suardi N, Salonia A, Bertini R, Gallina A, Bianchi M, Fantini GV, Bolognesi A, Fazio F, Montorsi F, Rigatti P.

Eur Urol. 2009 May;55(5):1003-11. doi: 10.1016/j.eururo.2009.01.046. Epub 2009 Feb 4.

PMID:
19211184
5.

Current status of pelvic lymph node dissection in prostate cancer: the New York PLND nomogram.

Kazzazi A, Djavan B.

Can J Urol. 2011 Apr;18(2):5585-91. Review.

PMID:
21504645
6.

Indications for pelvic nodal treatment in prostate cancer should change. Validation of the Roach formula in a large extended nodal dissection series.

Abdollah F, Cozzarini C, Suardi N, Gallina A, Capitanio U, Bianchi M, Tutolo M, Salonia A, La Macchia M, Di Muzio N, Rigatti P, Montorsi F, Briganti A.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):624-9. doi: 10.1016/j.ijrobp.2011.06.2014. Epub 2011 Nov 16.

PMID:
22099031
7.

Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy.

Briganti A, Karnes JR, Da Pozzo LF, Cozzarini C, Gallina A, Suardi N, Bianchi M, Freschi M, Doglioni C, Fazio F, Rigatti P, Montorsi F, Blute ML.

Eur Urol. 2009 Feb;55(2):261-70. doi: 10.1016/j.eururo.2008.09.043. Epub 2008 Oct 1.

PMID:
18838212
8.

Extending the indications and anatomical limits of pelvic lymph node dissection for prostate cancer: improved staging or increased morbidity?

Touijer K, Fuenzalida RP, Rabbani F, Paparel P, Nogueira L, Cronin AM, Fine SW, Guillonneau B.

BJU Int. 2011 Aug;108(3):372-7. doi: 10.1111/j.1464-410X.2010.09877.x. Epub 2010 Dec 24.

9.

Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.

Briganti A, Larcher A, Abdollah F, Capitanio U, Gallina A, Suardi N, Bianchi M, Sun M, Freschi M, Salonia A, Karakiewicz PI, Rigatti P, Montorsi F.

Eur Urol. 2012 Mar;61(3):480-7. doi: 10.1016/j.eururo.2011.10.044. Epub 2011 Nov 7.

PMID:
22078338
10.

Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.

Briganti A, Capitanio U, Chun FK, Gallina A, Suardi N, Salonia A, Da Pozzo LF, Colombo R, Di Girolamo V, Bertini R, Guazzoni G, Karakiewicz PI, Montorsi F, Rigatti P.

Eur Urol. 2008 Oct;54(4):794-802. doi: 10.1016/j.eururo.2008.05.018. Epub 2008 May 21.

PMID:
18514383
11.

The role of lymph node dissection in the management of prostate cancer.

Miki J, Egawa S.

Int J Clin Oncol. 2011 Jun;16(3):195-202. doi: 10.1007/s10147-011-0245-z. Epub 2011 May 10. Review.

PMID:
21556799
12.

Complications of pelvic lymph node dissection for prostate cancer.

Keegan KA, Cookson MS.

Curr Urol Rep. 2011 Jun;12(3):203-8. doi: 10.1007/s11934-011-0179-z. Review.

PMID:
21394597
13.

[The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].

Heidenreich A, Ohlmann CH.

Aktuelle Urol. 2005 Jun;36(3):219-29. German.

PMID:
16001337
14.

Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.

Suardi N, Larcher A, Haese A, Ficarra V, Govorov A, Buffi NM, Walz J, Rocco B, Borghesi M, Steuber T, Pini G, Briganti A, Mottrie AM, Guazzoni G, Montorsi F, Pushkar D, Van Der Poel H; EAU Young Academic Urologists–Robotic Section.

Eur Urol. 2014 Oct;66(4):635-43. doi: 10.1016/j.eururo.2013.12.059. Epub 2014 Jan 4.

PMID:
24411992
15.

Lymph node dissection in renal cell carcinoma.

Capitanio U, Becker F, Blute ML, Mulders P, Patard JJ, Russo P, Studer UE, Van Poppel H.

Eur Urol. 2011 Dec;60(6):1212-20. doi: 10.1016/j.eururo.2011.09.003. Epub 2011 Sep 13. Review.

PMID:
21940096
16.

External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.

Gacci M, Schiavina R, Lanciotti M, Masieri L, Serni S, Vagnoni V, Abdollah F, Carini M, Martorana G, Montorsi F.

Urol Int. 2013;90(3):277-82. doi: 10.1159/000343993. Epub 2012 Dec 22.

PMID:
23296120
17.

Assessing the risk of lymph node invasion in patients with intermediate risk prostate cancer treated with extended pelvic lymph node dissection. A novel prediction tool.

Briganti A, Capitanio U, Abdollah F, Gallina A, Suardi N, Bianchi M, Tutolo M, Salonia A, Freschi M, Rigatti P, Montorsi F.

Prostate. 2012 Apr;72(5):499-506.

PMID:
22468270
18.
19.

Regional lymph node staging in prostate cancer: prognostic and therapeutic implications.

Burkhard FC, Studer UE.

Surg Oncol. 2009 Sep;18(3):213-8. doi: 10.1016/j.suronc.2009.02.008. Epub 2009 Mar 9. Review.

PMID:
19269808
20.

Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.

Heck MM, Retz M, Bandur M, Souchay M, Vitzthum E, Weirich G, Mollenhauer M, Schuster T, Autenrieth M, Kübler H, Maurer T, Thalgott M, Herkommer K, Gschwend JE, Nawroth R.

Eur Urol. 2014 Aug;66(2):222-9. doi: 10.1016/j.eururo.2013.02.007. Epub 2013 Feb 18.

PMID:
23465520
Items per page

Supplemental Content

Write to the Help Desk